74 related articles for article (PubMed ID: 161470)
1. The tumor-forming type of multiple myeloma. II. Clinical profile and therapeutic effect.
Sezaki T; Hujita M; Oka A; Tanaka T
Acta Med Okayama; 1979 Dec; 33(6):451-4. PubMed ID: 161470
[TBL] [Abstract][Full Text] [Related]
2. Nonsecretory myeloma: analysis of two patients by immunoperoxidase studies and plaque-forming cell assay.
Matsuzaki H; Kagimoto T; Matsushita S; Matsuoka M; Tajima H; Yamamura F; Takatsuki K
Jpn J Clin Oncol; 1985 Jun; 15(2):467-73. PubMed ID: 3894717
[TBL] [Abstract][Full Text] [Related]
3. [Tumor-forming type IgA (kappa) multiple myeloma developed into polyclonal hyper gamma-globulinemia after M-protein loss].
Wakita M; Kotani S; Sezaki T; Murakami M; Ishii H; Hoshijima T; Nakayama S
Rinsho Ketsueki; 1991 Sep; 32(9):964-9. PubMed ID: 1942542
[TBL] [Abstract][Full Text] [Related]
4. [Clinico-pathological studies of tumor-forming type of multiple myeloma].
Fujii H; Seki S
Gan No Rinsho; 1983 Jul; 29(8):903-10. PubMed ID: 6887523
[TBL] [Abstract][Full Text] [Related]
5. [Biclonal myeloma (IgG and IgA)].
González Barón M; Martínez Fernández A; Durán A; Montero JM; Ordoñez A; Gasalla R
Rev Clin Esp; 1973 Feb; 128(4):345-8. PubMed ID: 4700587
[No Abstract] [Full Text] [Related]
6. Clinical classification of plasma cell myeloma.
Conklin R; Alexanian R
Arch Intern Med; 1975 Jan; 135(1):139-43. PubMed ID: 1111462
[TBL] [Abstract][Full Text] [Related]
7. [A case of multiple myeloma associated with a large subcutaneous mass in the frontal region].
Anda T; Baba H; Yonekura M; Moriyama T; Teramoto S; Fujii H
No Shinkei Geka; 1994 May; 22(5):455-60. PubMed ID: 8196832
[TBL] [Abstract][Full Text] [Related]
8. The tumor-forming type of multiple myeloma. I. Biological behavior.
Tanaka T; Sezaki T; Hujita M; Oka A; Okamoto T; Ito J
Acta Med Okayama; 1979 Oct; 33(5):359-70. PubMed ID: 160183
[TBL] [Abstract][Full Text] [Related]
9. Biclonal gammopathy in multiple myeloma: a case report.
Bakta IM; Sutarka IN
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous involvement in multiple myeloma: a clinicopathologic, immunohistochemical, and cytogenetic study of 8 cases.
Requena L; Kutzner H; Palmedo G; Calonje E; Requena C; Pérez G; Pastor MA; Sangueza OP
Arch Dermatol; 2003 Apr; 139(4):475-86. PubMed ID: 12707095
[TBL] [Abstract][Full Text] [Related]
11. [A case of multiple myeloma showing intracranial hypertension due to large cranial mass lesions].
Sugita K; Kayama T; Ohwada K; Ichinose M; Takasugi R; Ishizaki T
No To Shinkei; 1986 Jul; 38(7):625-9. PubMed ID: 3756028
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal plasmocytic myeloma with 2 paraproteins, IgG kappa and IgG lambdal].
Villiamey J; Bouvet JP; Di Menza C; Boccara M
Nouv Presse Med; 1974 Dec; 3(45):2707-11. PubMed ID: 4142506
[No Abstract] [Full Text] [Related]
13. Monoclonal IgD. A comparative study of 60 sera with IgD "M" component.
Fine JM; Rivat C; Lambin P; Ropartz C
Biomedicine; 1974 Mar; 21(3):119-25. PubMed ID: 4429767
[No Abstract] [Full Text] [Related]
14. [Treatment of multiple myeloma].
Clément F
Schweiz Med Wochenschr; 1986 Feb; 116(8):230-9. PubMed ID: 3082003
[TBL] [Abstract][Full Text] [Related]
15. Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness.
Morstyn G; Schechter GP; Ihde DC; Carney DN; Eddy JL; Cohen MH; Minna JD; Bunn PA
Cancer Treat Rep; 1984 Dec; 68(12):1439-46. PubMed ID: 6391662
[TBL] [Abstract][Full Text] [Related]
16. IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance.
Papadea C; Reimer CB; Check IJ
Ann Clin Lab Sci; 1989; 19(1):27-37. PubMed ID: 2492788
[TBL] [Abstract][Full Text] [Related]
17. [IgM type multiple myeloma expressing various surface adhesion molecules and demonstrating an aggressive clinical course].
Hirayama Y; Sakamaki S; Tsuji Y; Sagawa T; Chiba H; Matsunaga T; Kato J; Niitsu Y
Rinsho Ketsueki; 2003 Sep; 44(9):957-61. PubMed ID: 14577317
[TBL] [Abstract][Full Text] [Related]
18. [Plasmocytic pleural effusion disclosing multiple myeloma].
Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
[TBL] [Abstract][Full Text] [Related]
19. A case of multiple myeloma which developed into multiple extramedullary involvement in the terminal stage.
Umeno Y; Kogawa K; Matsuishi E; Miyamoto Y; Torii Y; Irie K; Kanda M; Ohshima K
Fukuoka Igaku Zasshi; 2000 Feb; 91(2):55-61. PubMed ID: 10769949
[TBL] [Abstract][Full Text] [Related]
20. Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria.
Sirohi B; Powles R; Kulkarni S; Rudin C; Saso R; Lal R; Singhal S; Mehta J; Horton C; Treleaven J
Bone Marrow Transplant; 2001 Jul; 28(1):29-37. PubMed ID: 11498741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
